Us vs Fluoroscopic Guided Renal Access (Puncture)

October 14, 2020 updated by: mostafa kamel abdel rahman abdel aal, Assiut University

Ultrasonography Versus Fluoroscopic Guided Renal Access

this present study is to compare the result of fluoroscopy, ultrasonography (US) in the guidance of percutaneous nephrostomy pcn .

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

investigators will enroll 100 patients who are candidates for PCN in the study. By simple random sampling technique, patients will be assigned to two patient groups (group 1, US-guided approach , group 2, fluoroscopy-guided approach.The end point of the study is the comparison of outcome of procedure including stone free rate, transfusion rate, operation time, access time, length of stay and complications.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sedfa
      • Assiut, Sedfa, Egypt, 11775
        • Recruiting
        • Mostafs Kamel Abdel Rahman
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 90 years (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • infected hydronephrotic kidney onen's grade 2-3
  • obstructed good cortex with backpressure changes onen's grade 2-3 .
  • Evaluation of function of asymptomatic hydronephrotic kidney thin cortex onen's grade 4

Exclusion Criteria:

  • congenital anomalies of kidney
  • patient underwent transplant or urinary diversion
  • solitary kidney

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Ultrasonographic guided renal access
The use of ultrasound to make a puncture in kidney for pcn for drainage or evaluation of function or for shunt of urine
The use of a needle for entering pelvicalyceal system of the kidney and put a guide wire for further pcn
EXPERIMENTAL: Fluoroscopic guided renal access
The use of fluoroscopy to make a puncture in kidney for pcn for drainage or evaluation of function or for shunt of urine
The use of a needle for entering pelvicalyceal system of the kidney and put a guide wire for further pcn

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of puncture
Time Frame: Within the operation
The time taken for make a puncture
Within the operation
duration of operation
Time Frame: withen the operation
time taken from patient putted on table until end of operation
withen the operation
Rate of success
Time Frame: withen the operation
the rate success of intervention by u/s or by fluoroscopy
withen the operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
rate of Perioperative complication
Time Frame: withen the operation
numbers of patients with Adverse effects occures intra operative ,bleeding ,extravasation
withen the operation
Haemoglobin concentration change
Time Frame: 24 hours post procedure
Compare preoperative and post operative Hg concentration
24 hours post procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Fathy G Elanany, Prof, Assiut
  • Study Director: Mohamed A Sayed, Prof, Assiut
  • Study Director: Hosney M Bahnasawy, Ass Prof, Assiut

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 10, 2019

Primary Completion (ANTICIPATED)

April 1, 2021

Study Completion (ANTICIPATED)

April 1, 2021

Study Registration Dates

First Submitted

September 11, 2019

First Submitted That Met QC Criteria

September 12, 2019

First Posted (ACTUAL)

September 16, 2019

Study Record Updates

Last Update Posted (ACTUAL)

October 19, 2020

Last Update Submitted That Met QC Criteria

October 14, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Renal puncture

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hydronephrosis

Clinical Trials on Renal puncture

Subscribe